To date, research studies on CBD have focused on their use for patients with a history of seizures. Researchers findings were so strong that the FDA approved the prescription CBD Epidiolex for the treatment of individuals experiencing chronic epilepsy. For the broader marketplace, the Consumer Reports study found that 75% of those who reported taking CBD stated that if was effective for the condition they took it for. Of those, 48% reported that it was extremely effective. Most respondents (over 75%) reported that either no or very limited side effects. This self reporting that side effects are very uncommon is promising for those looking for new solutions for health problems. Further, in the Consumer Reports survey, 22% of respondents who took CBD reported that it allowed them to use it rather than prescription or OTC drugs. One third of those stated that they used CBD to replace opioids. This last finding is driving new study in to whether CBD, either alone or in combination with THC, can be used to combat the ongoing opioid crisis in the United States.
Physicians do recommend considering the amount of CBD in any product that consumers consider purchasing. Mitch Earleywine, Ph.D, a professor of psychology, University of Albany, State University of New York, notes that many products will site the amount of CBD in each package rather than in each dose. Also, different products deliver different levels of CBD. For instance, capsules contain a precise amount of CBD in a dose while the amount of CBD a user receives from creams and oils differ depending on how often the consumer uses the product. It is recommended that consumers begin with lower levels of CBD, such as 10 mg. After using the product for a week or two, this dosage amount can be increased if needed. Individuals should not exceed 100 mg a day without consulting their medical care provider.